Q&A with Oncimmune CEO, Dr Adam M Hill

Onciummune CEO, Dr Adam Hill, discusses the Company’s latest contract wins with Roche and Cedars-Sinai along with the use of funds from their recent oversubscribed fundraise and what investors can expect for the remainder of 2021.

You might like

© 2022 Stockmark.it The Latest StockMarket News and Interviews